BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524202

LACTOSE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

LACTOSE (INDIA) LTD. Share Price Update

As of the latest trading session, LACTOSE (INDIA) LTD. share price is currently at ₹ 116.59, which is down by ₹ -2.37 from its previous closing. Today, the stock has fluctuated between ₹ 116.59 and ₹ 116.59. Over the past year, LACTOSE (INDIA) LTD. has achieved a return of -25.45 %. In the last month alone, the return has been 26.12 %. Read More...

LACTOSE (INDIA) LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    164.30

  • P/E Ratio (TTM)

    23.75

  • Beta

    0.44

  • Book Value / share

    55.00

  • Return on equity

    15.49%

  • EPS (TTM)

    4.91

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.22

info icon alternate text

LACTOSE (INDIA) LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 28.72
Operating Expense 28.75
Net Profit 0.22
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.17
EBITDA 3.52
Effective Tax Rate (%) 60.37
Particulars SEP 2024 (Values in Cr)
Revenue 30.45
Operating Expense 28.14
Net Profit 2.03
Net Profit Margin (%) 6.66
Earnings Per Share (EPS) 1.61
EBITDA 5.31
Effective Tax Rate (%) 21.83
Particulars JUN 2024 (Values in Cr)
Revenue 29.46
Operating Expense 26.46
Net Profit 2.27
Net Profit Margin (%) 7.70
Earnings Per Share (EPS) 1.80
EBITDA 5.80
Effective Tax Rate (%) 29.72
Particulars MAR 2024 (Values in Cr)
Revenue 29.40
Operating Expense 26.08
Net Profit 2.40
Net Profit Margin (%) 8.16
Earnings Per Share (EPS) 1.91
EBITDA 6.41
Effective Tax Rate (%) 33.70
Particulars DEC 2023 (Values in Cr)
Revenue 32.60
Operating Expense 29.28
Net Profit 2.63
Net Profit Margin (%) 8.06
Earnings Per Share (EPS) 2.09
EBITDA 6.00
Effective Tax Rate (%) 27.01
Particulars MAR 2024 (Values in Cr)
Revenue 113.89
Operating Expense 105.35
Net Profit 6.79
Net Profit Margin (%) 5.96
Earnings Per Share (EPS) 5.39
EBITDA 20.12
Effective Tax Rate (%) 29.81
Particulars MAR 2023 (Values in Cr)
Revenue 65.80
Operating Expense 65.05
Net Profit 1.21
Net Profit Margin (%) 1.83
Earnings Per Share (EPS) 0.96
EBITDA 12.10
Effective Tax Rate (%) 17.80
Particulars MAR 2022 (Values in Cr)
Revenue 45.94
Operating Expense 43.36
Net Profit 2.45
Net Profit Margin (%) 5.33
Earnings Per Share (EPS) 2.10
EBITDA 12.84
Effective Tax Rate (%) 22.71
Particulars MAR 2021 (Values in Cr)
Revenue 34.96
Operating Expense 38.55
Net Profit -2.48
Net Profit Margin (%) -7.09
Earnings Per Share (EPS) -2.40
EBITDA 6.54
Effective Tax Rate (%) 24.15
Particulars MAR 2020 (Values in Cr)
Revenue 40.05
Operating Expense 40.25
Net Profit 0.07
Net Profit Margin (%) 0.17
Earnings Per Share (EPS) 0.07
EBITDA 9.57
Effective Tax Rate (%) 30.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 37.41
ROE % 15.49
ROCE % 17.77
Total Debt to Total Equity 0.89
EBITDA Margin 17.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.22
ROE % 3.03
ROCE % 9.19
Total Debt to Total Equity 1.00
EBITDA Margin 18.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 31.21
ROE % 6.59
ROCE % 10.09
Total Debt to Total Equity 1.18
EBITDA Margin 27.97
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.15
ROE % -7.15
ROCE % 2.75
Total Debt to Total Equity 1.23
EBITDA Margin 18.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 33.65
ROE % 0.20
ROCE % 7.61
Total Debt to Total Equity 1.10
EBITDA Margin 23.90
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 100.73
Total Liabilities 100.73
Total Equity 47.09
Share Outstanding 12589000
Price to Book Ratio 3.73
Return on Assets (%) 6.73
Return on Capital (%) 7.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 101.29
Total Liabilities 101.29
Total Equity 40.56
Share Outstanding 12589000
Price to Book Ratio 1.36
Return on Assets (%) 1.19
Return on Capital (%) 1.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 90.22
Total Liabilities 90.22
Total Equity 39.28
Share Outstanding 12589000
Price to Book Ratio 1.92
Return on Assets (%) 2.71
Return on Capital (%) 3.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.66
Total Assets 88.34
Total Liabilities 88.34
Total Equity 35.08
Share Outstanding 11437000
Price to Book Ratio 0.89
Return on Assets (%) -2.80
Return on Capital (%) -3.07
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.88
Total Assets 84.00
Total Liabilities 84.00
Total Equity 34.28
Share Outstanding 10189000
Price to Book Ratio 0.50
Return on Assets (%) 0.08
Return on Capital (%) 0.1
Particulars MAR 2024 (Values in Cr)
Net Income 9.66
Cash from Operations 9.54
Cash from Investing -2.07
Cash from Financing -5.74
Net change in Cash 0.94
Free Cash Flow 11.73
Particulars MAR 2023 (Values in Cr)
Net Income 1.46
Cash from Operations 7.93
Cash from Investing -0.91
Cash from Financing -8.31
Net change in Cash -1.34
Free Cash Flow 9.49
Particulars MAR 2022 (Values in Cr)
Net Income 3.16
Cash from Operations 8.39
Cash from Investing -0.56
Cash from Financing -8.14
Net change in Cash -0.23
Free Cash Flow 9.72
Particulars MAR 2021 (Values in Cr)
Net Income -3.27
Cash from Operations 2.13
Cash from Investing -6.17
Cash from Financing 4.52
Net change in Cash 0.51
Free Cash Flow 7.62
Particulars MAR 2020 (Values in Cr)
Net Income 0.09
Cash from Operations 7.37
Cash from Investing -2.87
Cash from Financing -3.57
Net change in Cash 0.96
Free Cash Flow 10.44
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

LACTOSE (INDIA) LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
116.59 -1.99 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 118.60
  • 26 Days 113.80
  • 10 Days 116.70
  • 50 Days 122.60
  • 12 Days 115.70
  • 100 Days 140.50
  • 20 Days 113.60
  • 200 Days 149.40
118.96 PIVOT

First Support

118.96

First Resistance

118.96

Second Support

118.96

Second Resistance

118.96

Third Support

118.96

Third Resistance

118.96

RSI

53.65

ADX

12.67

MACD

1.91

Williams % R

-37.62

Commodity Channel Index (CCI)

58.81

Date

2025-04-30

Week

5166.00

Same Day

1350.00

Month

4633.00

1 Year

0.45

3 Year

0.61

Over 1 Month

26.12%

down

Over 1 Year

-25.45%

down

Over 3 Months

-38.00%

down

Over 3 Years

17.26%

down

Over 6 Months

-31.15%

down

Over 5 Years

44.12%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

LACTOSE (INDIA) LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
45.73%
Promoter Holdings
53.64%
FII
0.0%
DII
0.61%
Promoter Shares(Pledge Percentage)
26.07%
Name Shares Category
Sangita Maheshwari 3868951.0 (30.73%) Shareholding of Promoter and Promoter Group
Atul Maheshwari 1361010.0 (10.81%) Shareholding of Promoter and Promoter Group
Shyamsunder Bhorilal Toshniwal 750000.0 (5.96%) Shareholding of Promoter and Promoter Group
Madhusha Lifecare Pvt. Ltd 575184.0 (4.57%) Shareholding of Promoter and Promoter Group
Madhusha Holdings Private Limited 500000.0 (3.97%) Public Shareholding
Dotch Sales Private Limited 128000.0 (1.02%) Public Shareholding
Pushpa Suraj Maheshwari 112920.0 (0.9%) Shareholding of Promoter and Promoter Group
Atul Maheshwari . 50000.0 (0.4%) Shareholding of Promoter and Promoter Group
Yashvardhan Maheshwari 35361.0 (0.28%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

LACTOSE (INDIA) LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

LACTOSE (INDIA) LTD. Share Price

Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products.

The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad.

The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose.

In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section.

During the year 1995-96, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder.

During the year 2004-05, the company streamlined their pharmaceutical plant and entered into long-term contract manufacturing for one of the leading multinational company. They invested substantially in upgrading and renovating the Pharmaceutical facilities as per the requirement of the new Schedule M, as per the directives from the Food and Drug Administration. Also, they started a new equipment manufacture, assemble and export for Projects division in Kandla SEZ (Special Economic Zone).

During the year 2006-07, the company undertook major expansion programme at their existing production site for manufacturing of value added product 'LACTULOSE' which is a forward integration of their existing product 'LACTOSE'.

During the year 2007-08, the company successfully implemented the task undertaken last year and commissioned the new liquid orals division. During the year 2008-09, the company started manufacturing of Liquid Formulations.

The Company in 2010, formed strategic alliance with Kerry Group of Ireland for contract manufacturing Of lactose 10,000 Mt / Annum.

It started manufacturing for Dr Reddy's for their Liquid Oral Bottles in 2015. In 2016, it started Lactulose Manufacturing API Plant. In 2022, it started own marketing & sales of Lactose Monohydrate under the banner of Lactose (India) Limited.

The Company in 2023, launched production of Lactulose with state of art manufacturing facility. The Plant produces Lactulose Concentrate USP & Lactulose Solution USP/EP. It broadened the horizons by getting into contract manufacturing of Tablets, Liquid orals & Manufacturing of Finished Formulations.

Parent organization Toshniwal
NSE symbol [-]
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Lactose (India) Ltd?

Answer Field

The share price of Lactose (India) Ltd for NSE is ₹ 0.00 and for BSE is ₹ 116.59.

What is the Market Cap of Lactose (India) Ltd?

Answer Field

The market cap of Lactose (India) Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,64.30 Cr. as of now.

What is the 52 Week High and Low of Lactose (India) Ltd?

Answer Field

The 52 Week High and Low of Lactose (India) Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 247.40 and ₹ 84.27.

How to Buy Lactose (India) Ltd share?

Answer Field

You can trade in Lactose (India) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Lactose (India) Ltd?

Answer Field

The 1 year returns on the stock has been -25.45%.

What is the Current Share Price of Lactose (India) Ltd?

Answer Field

Lactose (India) Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 116.59 as on Apr 30 2025 03:15 PM.

What is the Market Cap of Lactose (India) Ltd Share?

Answer Field

The market cap of Lactose (India) Ltd for NSE ₹ 0.0 & for BSE ₹ 1,64.30 as on Apr 30 2025 03:15 PM.

What is the P/E Ratio of Lactose (India) Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM the price-to-earnings (PE) ratio for Lactose (India) Ltd share is 23.75.

What is the PB ratio of Lactose (India) Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM, the price-to-book (PB) ratio for Lactose (India) Ltd share is 55.00.

How to Buy Lactose (India) Ltd Share?

Answer Field

You can trade in Lactose (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lactose (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Lactose (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lactose (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|